Parkinson’s Disease
Parkinson’s Disease is a disorder of the central nervous system that affects movement, often including tremors.
Nerve cell damage in the brain causes dopamine levels to drop, leading to the symptoms of Parkinson’s.
Parkinson’s often starts with a tremor in one hand. Other symptoms are slow movement, stiffness, and loss of balance.
Medications can help control the symptoms of Parkinson’s.
Parkinson’s Disease is a progressive disease of the nervous system marked by tremor, muscular rigidity, and slow, imprecise movement, chiefly affecting middle-aged and elderly people. It is associated with degeneration of the basal ganglia of the brain and a deficiency of the neurotransmitter dopamine.
Symptoms:
Cluster Number:
Wiki Number: PW153
Diagnosis: Parkinson’s Disease (Very complex; please read the Wikipedia article.)
US Patients: 2-6X likelihood of dementia
World Patients: 6.2Mil&117,400 Deaths (2015)
Sex Ratio:
Age Onset: Over 60, usually; unless “early-onset Parkinson’s”
Brain Area: Cell deaths among the subantia nigra leads to dopamine deficits; Cells die from proteins into Lewy bodies in the neurons
Symptoms: tremor, slowness(bradykinesia), stiffness(excessive muscle contraction) and postural instability(10% fall weekly)
Progression: As it progresses, poor decision-making, less impulse control, impaired recall, less control of attention
Causes: genetics, injuries, pesticides;brain lesions from strokes;alpha-synuclein protein in the brain buildup; 50% have hallucinations
Medications: L-DOPA; deep brain stimulation by microelectrodes reduces muscular symptoms;
Therapies: Imaging by MRI, T2* and SW;, neuromelanin-MRI; Diffusion, MRI; PET; SPECT; DaTSCAN is the only FDA approved way to distinguish.
Youtube Video: Parkinson’s Disease: Adversity or Adventure?
Amazon or Library Book:
Parkinson’s Disease – Guide for the Newly Diagnosed
Click the book to link or buy from Amazon.
Support Group: parkinsons.org; 800-473-4636
(Parkinson’s Disease Foundation)
Support Group:michaeljfox.org; (Primarily designed to find a cure for Parkinson’s Disease. It may also have support groups.)
Contact your local Social Security office for possible Disability Benefits through their Disability Determination Services,
Section 12.02.
4 CURRENT ARTICLES
FROM PUBMED
The world-wide medical research
reports chosen for each diagnosis
Clicking each title opens the
PubMed article’s summary-abstract.
- Amygdala-centered fusional connections characterized nonmotor symptoms in Parkinson's diseaseby Yi Zhang on January 22, 2025
The importance of nonmotor symptoms in understanding the pathogenesis of the heterogeneity of Parkinson's disease has been highlighted. However, the validation of specific brain network biomarkers in nonmotor symptom subtypes is currently lacking. By performing a new approach to compute functional connectivity with structural prior using magnetic resonance imaging, the present study computed both functional connectivity and fusional connectivity features in the nonmotor symptom subtypes of...
- Cost-utility analysis of a coadjutant telemedicine intervention for fall prevention in Parkinson's diseaseby Esther Cubo on January 22, 2025
CONCLUSIONS: Telemedicine could be considered an efficient coadjutant intervention for PD, especially for non-motor symptoms, enhancing health outcomes and accessibility.
- Altered effective connectivity in Parkinson's disease patients with rapid eye movement sleep behavior disorder: a resting-state functional magnetic resonance imaging study and support vector machine analysisby Ai-Di Shan on January 22, 2025
CONCLUSIONS: The altered z-DC in the right precentral gyrus and the anomaly causal effects from the precentral motor cortex to the ipsilateral striatum represented by the caudate nucleus might play vital roles in the pathogenesis of PD-pRBD. It was speculated that the attenuation of FC from the precentral motor cortex to the subcortical striatum might be associated with nocturnal muscle dyskinesia and behavioral abnormalities in PD-pRBD patients. This disruption pattern may be a prospective...
- Mitochondria-Related Genome-Wide Mendelian Randomization Identifies Putatively Causal Genes for Neurodegenerative Diseasesby Zheyi Wang on January 22, 2025
CONCLUSIONS: This data-driven MR study demonstrated the causal role of mitochondrial dysfunction in NDDs. Additionally, this study identified candidate genes that could serve as potential pharmacological targets for the prevention and treatment of NDDs. © 2025 International Parkinson and Movement Disorder Society.